Gly-Gly

CAS : 556-50-3

Ref. 3D-OGG-3028

Informations sur le produit

• Nom: Gly-Gly
• Synonymes: Glycyl-Glycine, 13: PN: WO2017167712 SEQID: 23 claimed protein, 16: PN: WO2021041934 SEQID: 69 claimed protein, 2-(2-Aminoacetamido)acetic acid, 2-(Aminoacetamido)acetic acid, 2-[(2-Aminoacetyl)amino]acetic acid, 29: PN: US20200095309 SEQID: 56 claimed protein, 31: PN: FR2860236 PAGE: 10 claimed protein, 38: PN: WO2020048525 SEQID: 46 claimed protein, 4: PN: WO2018201047 SEQID: 102 claimed protein, 89: PN: WO2019035010 SEQID: 89 claimed protein, Diglycine, Diglycocoll, G 0124, Gly-Gly Free Base, Gly2, Gly₂, Glycine dipeptide, Glycine, Glycyl, Glycine, N-glycyl-, Glycine-glycine, Glycyl-glycine,(Diglycine), Glycylglycine, Free Base, H-Gly-Gly-OH, N-Glycyl-Glycine, N-Glycylglycin, N-Glycylglycine, N-glicilglicina, Nsc 49346, α-Glycylglycine, Glycylglycine

Description

Gly-Gly is a natural compound that belongs to the group of esters. It has been shown to have an antioxidative effect in vitro and in vivo. Gly-Gly has been shown to inhibit the growth of carcinoma cells by binding with hydrogen bonding interactions, which leads to cell death. This compound also has a strong antibacterial efficacy against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). In addition, gly-gly has been shown to be effective against Mycobacterium tuberculosis and Mycobacterium avium complex. This compound may be useful for treating infectious diseases caused by Gram-positive bacteria such as MRSA or methicillin resistant Staphylococcus aureus (MRSA).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 132.12 g/mol
• Formule: C₄H₈N₂O₃
• Degré de pureté: Min. 95%